Who owns Enzon Pharmaceuticals?

Key details on Enzon Pharmaceuticals (Ticker: ENZN)

Who owns Enzon Pharmaceuticals?

Is ENZN a good stock to own? Find out who bought Enzon Pharmaceuticals, who sold Enzon Pharmaceuticals (ENZN) stock, and who holds a large position in Enzon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
CARL C. ICAHN, INDIVIDUAL 5.90M $6.38M Sept. 30, 2014
Icahn Capital 4.72M $51.49M March 31, 2011
Baupost 4.34M $5.03M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 3.06M $3.30M Sept. 30, 2014
Artisan Partners Holdings 2.35M $23.63M June 30, 2011
Brenner West Capital Advisors 2.01M $13.98M Sept. 30, 2012
Renaissance Technologies 1.57M $1.70M Sept. 30, 2014
Great-West Life Assurance Company 1.44M $5.44M March 31, 2013
STATE STREET CORPORATION 1.42M $1.46M March 31, 2014
Iridian Asset Management 1.41M $9.81M Sept. 30, 2012
North Run Capital 1.38M $9.40M March 31, 2012
Artisan Partners Limited Partnership 1.37M $5.22M March 31, 2013
Vanguard 1.29M $1.38M Sept. 30, 2014
First Eagle Investment Management 1.12M $7.73M June 30, 2012
DIMENSIONAL FUND ADVISORS 1.10M $1.19M Sept. 30, 2014
BlackRock Fund Advisors 1.07M $1.10M March 31, 2014
Brandes Investment Partners 1.03M $1.12M Sept. 30, 2014
New Mountain Vantage Advisers 1.03M $7.18M Sept. 30, 2012
FMR 914365 $1.06M Dec. 31, 2013
Schroder Investment Management 886500 $957420 Sept. 30, 2014

Who sold Enzon Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
UBS AG Sept. 30, 2011 1.22M $8.62M
Perry June 30, 2011 2.01M $20.23M